BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37380106)

  • 1. Liver-adipose tissue crosstalk in non-alcoholic fatty liver disease: The emerging role of remnant cholesterol.
    Liu Y; Chen M
    J Hepatol; 2024 Mar; 80(3):e111-e112. PubMed ID: 37380106
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease: the emerging role of remnant cholesterol": "BAT activation might improve NAFLD in patients, but this might require developing and/or maintaining functionally relevant levels of BAT mass.".
    Lee E; Korf H; Vidal-Puig A
    J Hepatol; 2024 Mar; 80(3):e112-e114. PubMed ID: 37898347
    [No Abstract]   [Full Text] [Related]  

  • 3. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.
    Wang X; Rao H; Liu F; Wei L; Li H; Wu C
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.
    Romualdo GR; Valente LC; Sprocatti AC; Bacil GP; de Souza IP; Rodrigues J; Rodrigues MAM; Vinken M; Cogliati B; Barbisan LF
    Nutrition; 2022; 103-104():111836. PubMed ID: 36202025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?
    Cordeiro A; Costa R; Andrade N; Silva C; Canabrava N; Pena MJ; Rodrigues I; Andrade S; Ramalho A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):394-402. PubMed ID: 32044284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).
    Zhang X; Ji X; Wang Q; Li JZ
    Protein Cell; 2018 Feb; 9(2):164-177. PubMed ID: 28643267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
    Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
    World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Non Alcoholic Fatty Liver Disease.
    Petta S; Gastaldelli A; Rebelos E; Bugianesi E; Messa P; Miele L; Svegliati-Baroni G; Valenti L; Bonino F
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of chemerin and the influence of sitagliptin on its expression in non-alcoholic fatty liver disease rats complicated with prediabetes].
    Zhang L; Gao XF; Wang YH
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2407-2413. PubMed ID: 30138985
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophages as Key Players during Adipose Tissue-Liver Crosstalk in Nonalcoholic Fatty Liver Disease.
    Korf H; Boesch M; Meelberghs L; van der Merwe S
    Semin Liver Dis; 2019 Jul; 39(3):291-300. PubMed ID: 31041786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.
    Panera N; Della Corte C; Crudele A; Stronati L; Nobili V; Alisi A
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):393-403. PubMed ID: 26654761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease.
    Zubáňová V; Červinková Z; Kučera O; Palička V
    Acta Medica (Hradec Kralove); 2021; 64(1):1-7. PubMed ID: 33855952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome.
    Gathercole LL; Hazlehurst JM; Armstrong MJ; Crowley R; Boocock S; O'Reilly MW; Round M; Brown R; Bolton S; Cramb R; Newsome PN; Semple RK; Paisey R; Tomlinson JW; Geberhiwot T
    Liver Int; 2016 Nov; 36(11):1704-1712. PubMed ID: 27178444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
    Thondam SK; Cuthbertson DJ; Wilding JPH
    Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease.
    Eslam M; George J
    Hepatol Int; 2019 Nov; 13(6):662-664. PubMed ID: 31586267
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
    Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
    J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographically measured suprailiac adipose tissue is a useful predictor of non-alcoholic fatty liver disease in obese children and adolescents.
    Schlieske C; Denzer C; Wabitsch M; Oeztuerk S; Mason RA; Thiere D; Kratzer W
    Pediatr Obes; 2015 Aug; 10(4):260-6. PubMed ID: 25251446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the relationship between non-alcoholic fatty liver disease and coronary artery disease.
    Topuz M; Dogan A; Celik A; Can C; Ozdogru I; Kemal Eryol N
    Clin Ter; 2014; 165(1):e46-51. PubMed ID: 24589960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.